DexCom to release earnings on May 1, 2025, with high volatility historically around earnings

From Nasdaq: 2025-04-29 23:10:00

DexCom (NASDAQ:DXCM) will release earnings on May 1, 2025. Stock has had high volatility around earnings, with 61% negative one-day returns in the past five years, median return of -8.2%, and max return of -40.7%. Consensus estimates for Q1 2025 are $0.33 EPS on $1.02 billion revenue, compared to $0.32 EPS on $921 million revenue last year.

Understanding historical earnings trends can give traders an edge. Strategies include analyzing probabilities before release and examining correlation between immediate and medium-term returns post-announcement. DexCom’s market cap is $28 billion, with $4.0 billion revenue, $600 million operating profits, and $576 million net income. Consider the Trefis High Quality portfolio for lower volatility than individual stocks.

Historical data shows 39% positive one-day returns after earnings in the past five years, increasing to 45% in the last 3 years. Median of positive returns is 9.3%, while median of negative returns is -5.0%. Consider correlation between 1D, 5D, and 21D returns post earnings to inform trading decisions. Peer performance can also impact stock reaction post-earnings. Trefis RV strategy has outperformed all-cap stocks benchmark, offering strong returns for investors.



Read more at Nasdaq: DexCom Earnings: What To Expect For The Stock?